Abstract:T7 RNA polymerase (T7 RNAP) is the preferred tool for in vitro transcription (IVT), it synthesizes mRNA while accompanied by the generation of dsRNA by-products. This undesirable dsRNA triggers immune stress responses, compromises therapeutic efficacy, and raises safety concerns. To evolve T7 RNAP for reduced dsRNA, we pursued two complementary strategies. Firstly, the FADS (fluorescence-activated droplet sorting) based on molecular beacons was used to screen randomly libraries with diversity exceeding 10^5. Secondly, we constructed several single-site saturated libraries aimed at reducing the free energy of T7 RNAP elongation conformation. These libraries were screened using the traditional microplate-based dual-probe screening technique. Both approaches identified two dominant variants: Mut1 (V214A) and Mut7 (F162S/A247T) from FADS, Mut11 (K180E) and Mut14 (A70Q) from saturated libraries. Furthermore, the combinatorial mutant Mut17 (A70Q/F162S/K180E), generated via DNA shuffling, exhibited significantly reduced dsRNA production compared to the wild-type under various conditions, ranging from 0.18% to 1.80%, with a minimum value of 0.5 pg/ug. Cell experiments confirmed that variants generated capped-mRNA with similar quality and quantity to the wild-type, while significantly reducing immune stress response in cells. These results indicate the compatibility and broad potential applications of these mutations. We then observed a close correlation between the production of dsRNA and the activities of T7 RNAP in terminal transferase and RDRP. Particularly, the terminal transferase activity appears to play a critical role in dsRNA generation. These findings align with the mechanism of dsRNA formation during IVT and provide new screening criteria for further evolution of T7 RNAP.

FADS and semi-rational design modified T7 RNA polymerase reduced dsRNA production, with lower terminal transferase and RDRP activities

A Single Mutation Attenuates Both the Transcription Termination and RNA-dependent RNA Polymerase Activity of T7 RNA Polymerase

An engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis

Psychrophilic Phage VSW-3 RNA Polymerase Reduces Both Terminal and Full-Length Dsrna Byproducts in in Vitro Transcription

DNA-terminus-dependent transcription by T7 RNA polymerase and its C-helix mutants.

Evolution of C‐Terminal Modification Tolerance in Full‐Length and Split T7 RNA Polymerase Biosensors

Effective synthesis of circRNA via a thermostable T7 RNA polymerase variant as the catalyst

Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced

Advances in evolved T7 RNA polymerases for expanding the frontiers of enzymatic nucleic acid synthesis

Formation of dsRNA by-products during in vitro transcription can be reduced by using low steady-state levels of UTP

Direct Dsrna Preparation by Promoter-Free RCT and RNase H Cleavage Using One Circular Dsdna Template with a Mismatched Bubble

Predictable Control of RNA Lifetime Using Engineered Degradation-Tuning RNAs

Comprehensive evaluation of T7 promoter for enhanced yield and quality in mRNA production

Mrna Produced by VSW-3 RNAP Has High-Level Translation Efficiency with Low Inflammatory Stimulation

Engineered Stop and Go T7 RNA Polymerases

Enhancing the expression of terminal deoxynucleotidyl transferases by N‐terminal truncation

Recombinant T7 RNA polymerase production using ClearColi BL21(DE3) and animal-free media for in vitro transcription

Selective Binding to Mrna Duplex Regions by Chemically Modified Peptide Nucleic Acids Stimulates Ribosomal Frameshifting

Structural insight into RNA synthesis by influenza D polymerase

Visualized and Precise Design of Artificial Small RNAs for Regulating T7 RNA Polymerase and Enhancing Recombinant Protein Folding in Escherichia Coli.

A massively parallel in vivo assay of TdT mutants yields variants with altered nucleotide insertion biases